PRAX stock news
This page provides real-time market news, earnings updates, and company announcements related to Praxis Precision Medicines, Inc. (PRAX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-08 11:09 EST
Palantir receives an upgrade, Best Buy faces a downgrade: Leading analyst recommendations from Wall Street
101 finance2026-02-02 14:57:29
Guggenheim Raises Target on Praxis Precision Medicines (PRAX) to $800
Finviz2026-02-13 14:54:40
Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)
Finviz2026-02-16 17:24:49
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:33:03
Praxis Precision Medicines, Inc. (Praxis) recently disclosed the company's operational progress and financial report for the fourth quarter and full year of 2025.
老虎证券2026-02-19 12:40:00
Here's Why You Should Retain Honeywell Stock in Your Portfolio
Finviz2026-03-02 18:57:38
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom
101 finance2026-03-16 14:48:51
This biotech stock, which has surged by 700%, remains one of the leading holdings even after a $9.3 million sale in the previous quarter.
101 finance2026-03-16 22:51:48
Biotech shares remain 700% higher even after a 30% decline this year, following a fund's $9 million withdrawal.
101 finance2026-03-18 18:00:47
Biotech share remains 700% higher even after a 30% decline this year as a fund reveals a $9 million withdrawal
101 finance2026-03-18 18:15:44
Driehaus's $80M Bet on Praxis vs. CEO's $1M Exit: Institutional Conviction or Leadership Doubt?
101 finance2026-03-20 16:51:50
Gameto’s $44M Raise Signals Market Optimism Not Yet Priced in Stock
101 finance2026-03-21 22:54:52
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:04:13
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
Finviz2026-03-30 20:06:12
Praxis Rises on Momentum, Not Fundamentals
101 finance2026-04-02 01:25:07
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-02 20:03:43
Praxis Precision Medicines announced that its investigational drug Elsunersen demonstrated good tolerability in clinical trials.
老虎证券2026-04-06 12:10:56
Praxis Precision Medicines, Inc. (Praxis) recently disclosed the company's operational progress and financial report for the fourth quarter and full year of 2025.
老虎证券2026-02-19 12:40:00
Here's Why You Should Retain Honeywell Stock in Your Portfolio
Finviz2026-03-02 18:57:38
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom
101 finance2026-03-16 14:48:51
This biotech stock, which has surged by 700%, remains one of the leading holdings even after a $9.3 million sale in the previous quarter.
101 finance2026-03-16 22:51:48
Biotech shares remain 700% higher even after a 30% decline this year, following a fund's $9 million withdrawal.
101 finance2026-03-18 18:00:47
Biotech share remains 700% higher even after a 30% decline this year as a fund reveals a $9 million withdrawal
101 finance2026-03-18 18:15:44
Driehaus's $80M Bet on Praxis vs. CEO's $1M Exit: Institutional Conviction or Leadership Doubt?
101 finance2026-03-20 16:51:50
Gameto’s $44M Raise Signals Market Optimism Not Yet Priced in Stock
101 finance2026-03-21 22:54:52
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:04:13
Praxis Precision Medicines Announces FDA Acceptance and Priority Review of New Drug Application for Relutrigine in Patients with SCN2A and SCN8A DEEs
Finviz2026-03-30 20:06:12
Praxis Rises on Momentum, Not Fundamentals
101 finance2026-04-02 01:25:07
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-04-02 20:03:43
Praxis Precision Medicines announced that its investigational drug Elsunersen demonstrated good tolerability in clinical trials.
老虎证券2026-04-06 12:10:56
PRAX stock chart
PRAX stock detailsPRAX stock price change
On the last trading day, PRAX stock closed at 310.11 USD, with a price change of -0.09% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more